Dual Biomarker Assays Market By Product Type (Immunochemistry Assay, In-situ Hybridization (ISH) Assay, Next-Generation Sequencing (NGS) Kits, and Others), By Application (Cancer, Non-Small Cell Lung Cancer (NSCLC), Human Papillomavirus (HPV), Glioma, Gastrointestinal Cancer, Breast Cancer, B-Cell Lymphoma, and Alzheimer’s Disease), By End-user (Hospitals, Specialty Clinics, Diagnostic Laboratories, and Cancer Research Institutes), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Nov 2025
- Report ID: 164899
- Number of Pages: 198
- Format:
-
keyboard_arrow_up
-
-
- Hoffmann‑La Roche Ltd
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Fujirebio
- QIAGEN N.V.
- Bio‑Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Abbott Laboratories
- Siemens Healthineers AG
- Myriad Genetics, Inc.
Our Clients
- 164899
- Nov 2025
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
